home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Dissolution testing for the pharmaceutical industry

 
  November 29, 2011  
     
 
Royal Pharmaceutical Society , London
20-06-2012


By the end of the course you will have received an intensive course of study on the relevance of dissolution testing to the assessment of dosage forms
(in particular oral dosage forms), dissolution method development, validation and

  • You will understand:
    • the relevance of dissolution testing to industry & regulators
    • dissolution equipment
    • dissolution media
    • compendial requirements & testing
    • method development
    • method validation
  • Learn about the current state of knowledge of the subject, both in terms of theoretical basis and practical experience.
  • Acquire skills and knowledge you will be able to apply to day-to-day problems in dissolution testing, linked to a sound theoretical knowledge of the principles involved.
  • Formed lasting contacts with colleagues in the field, as well as the expert course tutors.
 
 
Organized by: Royal Pharmaceutical Society
Invited Speakers:
James Butler - Science Manager, GSK, Ware
Paul Dickinson - AstraZeneca, Macclesfield
Lee Dowden - MSD, Hoddesdon
Nikoletta Fotaki - University of Bath
Dave Holt - AstraZeneca, Macclesfield
Evangelos Kotzagiogis - Science Administrator, EMA, London
James Mann - MSD, Hoddesdon
Terry Way - USP Consultant, Cambridge
 
Deadline for Abstracts: 20-06-2012
 
Registration: To register for this event please go to: https://www.rpharms.com/events-and-courses/dissolution-testing.asp
E-mail: events@rpharms.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.